Seeking Alpha

Arrowhead Research Corporation (ARWR)

  • jgtragesser | Send Message 25 Jun

    $ARWR Receives Reg Clearance to Begin Additional Ph 2b Studies of Hep B Candidate ARC-520...
      • WItrader18 | Send Message 19 Jun

        Sold $ARWR from buy on 4/21 $6.75 --> $7.20 + $0.45 covered call option expired on 5/15 for 13.3% gain
        Reply (20)
      • View all 20 replies
        • oneotherfool | Send Message 19 Jun
          : I agree, i'll be looking for a pull back if we get it. We should fill that gap... Loved the commission free :)
        • tradebr2010 | Send Message 19 Jun
          : I think you could count on profit x margin if you sell a naked call/put.
          • creepus | Send Message 17 Jun

            Swing Trading Ideas - Charts $CVEO $VIP $DNR $PVA $GALT $OREX $HIMX $ARWR $SGYP $AXPW $ARTX
              • ScottyGreen | Send Message 3 Jun

                $ARWR NICE! on 6/3/15 at Jefferies conference, CEO Chris Anzalone just stated that they are "about 2 years ahead of the competition" in HBV
                Reply (1)
                • WItrader18 | Send Message 3 Jun
                  : Nice! is right! Thanks for the update
                  • WItrader18 | Send Message 15 May

                    $ARWR $7 cc options expiring today worthless, unless a massive pop comes :)
                      • WItrader18 | Send Message 7 May

                        Sold may 15th covered calls on $ARWR for $0.45 at $7 strike
                        Reply (1)
                        • delprice | Send Message 12 May
                          : same
                          • WItrader18 | Send Message 23 Apr

                            $SGMO and $ARWR leading the charge today.
                              • WItrader18 | Send Message 21 Apr

                                Increase position 200% in $ARWR at $6.75
                                  • Clinically Sound Investor | Send Message 15 Apr

                                    Buy Arrowhead Research Corporation On The Dip $ARWR
                                      • WItrader18 | Send Message 13 Apr

                                        $ADMP $ARWR $EPRS all more than 5% gainers on the day. $EPRS was a buy from 4/7
                                          Visit Seeking Alpha's
                                          ARWR vs. ETF Alternatives
                                          Company Description
                                          Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States